Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sickle-cell Anemia Therapeutics Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Blood Transfusion
1.2.3 Pharmacotherapy
1.2.4 Bone Marrow Transplant
1.3 Market by User
1.3.1 Global Sickle-cell Anemia Therapeutics Market Growth by User: 2018 VS 2022 VS 2033
1.3.2 Child
1.3.3 Adult
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Sickle-cell Anemia Therapeutics Market Perspective (2018-2033)
2.2 Sickle-cell Anemia Therapeutics Growth Trends by Region
2.2.1 Global Sickle-cell Anemia Therapeutics Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Sickle-cell Anemia Therapeutics Historic Market Size by Region (2018-2023)
2.2.3 Sickle-cell Anemia Therapeutics Forecasted Market Size by Region (2024-2033)
2.3 Sickle-cell Anemia Therapeutics Market Dynamics
2.3.1 Sickle-cell Anemia Therapeutics Industry Trends
2.3.2 Sickle-cell Anemia Therapeutics Market Drivers
2.3.3 Sickle-cell Anemia Therapeutics Market Challenges
2.3.4 Sickle-cell Anemia Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sickle-cell Anemia Therapeutics Players by Revenue
3.1.1 Global Top Sickle-cell Anemia Therapeutics Players by Revenue (2018-2023)
3.1.2 Global Sickle-cell Anemia Therapeutics Revenue Market Share by Players (2018-2023)
3.2 Global Sickle-cell Anemia Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Sickle-cell Anemia Therapeutics Revenue
3.4 Global Sickle-cell Anemia Therapeutics Market Concentration Ratio
3.4.1 Global Sickle-cell Anemia Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sickle-cell Anemia Therapeutics Revenue in 2022
3.5 Sickle-cell Anemia Therapeutics Key Players Head office and Area Served
3.6 Key Players Sickle-cell Anemia Therapeutics Product Solution and Service
3.7 Date of Enter into Sickle-cell Anemia Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Sickle-cell Anemia Therapeutics Breakdown Data by Type
4.1 Global Sickle-cell Anemia Therapeutics Historic Market Size by Type (2018-2023)
4.2 Global Sickle-cell Anemia Therapeutics Forecasted Market Size by Type (2024-2033)
5 Sickle-cell Anemia Therapeutics Breakdown Data by User
5.1 Global Sickle-cell Anemia Therapeutics Historic Market Size by User (2018-2023)
5.2 Global Sickle-cell Anemia Therapeutics Forecasted Market Size by User (2024-2033)
6 North America
6.1 North America Sickle-cell Anemia Therapeutics Market Size (2018-2033)
6.2 North America Sickle-cell Anemia Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Sickle-cell Anemia Therapeutics Market Size by Country (2018-2023)
6.4 North America Sickle-cell Anemia Therapeutics Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Sickle-cell Anemia Therapeutics Market Size (2018-2033)
7.2 Europe Sickle-cell Anemia Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Sickle-cell Anemia Therapeutics Market Size by Country (2018-2023)
7.4 Europe Sickle-cell Anemia Therapeutics Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Sickle-cell Anemia Therapeutics Market Size (2018-2033)
8.2 Asia-Pacific Sickle-cell Anemia Therapeutics Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Sickle-cell Anemia Therapeutics Market Size by Region (2018-2023)
8.4 Asia-Pacific Sickle-cell Anemia Therapeutics Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Sickle-cell Anemia Therapeutics Market Size (2018-2033)
9.2 Latin America Sickle-cell Anemia Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Sickle-cell Anemia Therapeutics Market Size by Country (2018-2023)
9.4 Latin America Sickle-cell Anemia Therapeutics Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Sickle-cell Anemia Therapeutics Market Size (2018-2033)
10.2 Middle East & Africa Sickle-cell Anemia Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Sickle-cell Anemia Therapeutics Market Size by Country (2018-2023)
10.4 Middle East & Africa Sickle-cell Anemia Therapeutics Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Addmedica
11.1.1 Addmedica Company Detail
11.1.2 Addmedica Business Overview
11.1.3 Addmedica Sickle-cell Anemia Therapeutics Introduction
11.1.4 Addmedica Revenue in Sickle-cell Anemia Therapeutics Business (2018-2023)
11.1.5 Addmedica Recent Development
11.2 Gamida Cell
11.2.1 Gamida Cell Company Detail
11.2.2 Gamida Cell Business Overview
11.2.3 Gamida Cell Sickle-cell Anemia Therapeutics Introduction
11.2.4 Gamida Cell Revenue in Sickle-cell Anemia Therapeutics Business (2018-2023)
11.2.5 Gamida Cell Recent Development
11.3 GlycoMimetics
11.3.1 GlycoMimetics Company Detail
11.3.2 GlycoMimetics Business Overview
11.3.3 GlycoMimetics Sickle-cell Anemia Therapeutics Introduction
11.3.4 GlycoMimetics Revenue in Sickle-cell Anemia Therapeutics Business (2018-2023)
11.3.5 GlycoMimetics Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Detail
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Sickle-cell Anemia Therapeutics Introduction
11.4.4 Pfizer Revenue in Sickle-cell Anemia Therapeutics Business (2018-2023)
11.4.5 Pfizer Recent Development
11.5 Novartis
11.5.1 Novartis Company Detail
11.5.2 Novartis Business Overview
11.5.3 Novartis Sickle-cell Anemia Therapeutics Introduction
11.5.4 Novartis Revenue in Sickle-cell Anemia Therapeutics Business (2018-2023)
11.5.5 Novartis Recent Development
11.6 Global Blood Therapeutics
11.6.1 Global Blood Therapeutics Company Detail
11.6.2 Global Blood Therapeutics Business Overview
11.6.3 Global Blood Therapeutics Sickle-cell Anemia Therapeutics Introduction
11.6.4 Global Blood Therapeutics Revenue in Sickle-cell Anemia Therapeutics Business (2018-2023)
11.6.5 Global Blood Therapeutics Recent Development
11.7 Micelle BioPharma
11.7.1 Micelle BioPharma Company Detail
11.7.2 Micelle BioPharma Business Overview
11.7.3 Micelle BioPharma Sickle-cell Anemia Therapeutics Introduction
11.7.4 Micelle BioPharma Revenue in Sickle-cell Anemia Therapeutics Business (2018-2023)
11.7.5 Micelle BioPharma Recent Development
11.8 Bluebird Bio
11.8.1 Bluebird Bio Company Detail
11.8.2 Bluebird Bio Business Overview
11.8.3 Bluebird Bio Sickle-cell Anemia Therapeutics Introduction
11.8.4 Bluebird Bio Revenue in Sickle-cell Anemia Therapeutics Business (2018-2023)
11.8.5 Bluebird Bio Recent Development
11.9 Prolong Pharmaceuticals
11.9.1 Prolong Pharmaceuticals Company Detail
11.9.2 Prolong Pharmaceuticals Business Overview
11.9.3 Prolong Pharmaceuticals Sickle-cell Anemia Therapeutics Introduction
11.9.4 Prolong Pharmaceuticals Revenue in Sickle-cell Anemia Therapeutics Business (2018-2023)
11.9.5 Prolong Pharmaceuticals Recent Development
11.10 Modus Therapeutics
11.10.1 Modus Therapeutics Company Detail
11.10.2 Modus Therapeutics Business Overview
11.10.3 Modus Therapeutics Sickle-cell Anemia Therapeutics Introduction
11.10.4 Modus Therapeutics Revenue in Sickle-cell Anemia Therapeutics Business (2018-2023)
11.10.5 Modus Therapeutics Recent Development
11.11 Sangamo Biosciences
11.11.1 Sangamo Biosciences Company Detail
11.11.2 Sangamo Biosciences Business Overview
11.11.3 Sangamo Biosciences Sickle-cell Anemia Therapeutics Introduction
11.11.4 Sangamo Biosciences Revenue in Sickle-cell Anemia Therapeutics Business (2018-2023)
11.11.5 Sangamo Biosciences Recent Development
11.12 Bioverativ
11.12.1 Bioverativ Company Detail
11.12.2 Bioverativ Business Overview
11.12.3 Bioverativ Sickle-cell Anemia Therapeutics Introduction
11.12.4 Bioverativ Revenue in Sickle-cell Anemia Therapeutics Business (2018-2023)
11.12.5 Bioverativ Recent Development
11.13 Imara
11.13.1 Imara Company Detail
11.13.2 Imara Business Overview
11.13.3 Imara Sickle-cell Anemia Therapeutics Introduction
11.13.4 Imara Revenue in Sickle-cell Anemia Therapeutics Business (2018-2023)
11.13.5 Imara Recent Development
11.14 Ironwood Pharmaceuticals
11.14.1 Ironwood Pharmaceuticals Company Detail
11.14.2 Ironwood Pharmaceuticals Business Overview
11.14.3 Ironwood Pharmaceuticals Sickle-cell Anemia Therapeutics Introduction
11.14.4 Ironwood Pharmaceuticals Revenue in Sickle-cell Anemia Therapeutics Business (2018-2023)
11.14.5 Ironwood Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Sickle-cell Anemia Therapeutics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Blood Transfusion
Table 3. Key Players of Pharmacotherapy
Table 4. Key Players of Bone Marrow Transplant
Table 5. Global Sickle-cell Anemia Therapeutics Market Size Growth by User (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Sickle-cell Anemia Therapeutics Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Sickle-cell Anemia Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Sickle-cell Anemia Therapeutics Market Share by Region (2018-2023)
Table 9. Global Sickle-cell Anemia Therapeutics Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Sickle-cell Anemia Therapeutics Market Share by Region (2024-2033)
Table 11. Sickle-cell Anemia Therapeutics Market Trends
Table 12. Sickle-cell Anemia Therapeutics Market Drivers
Table 13. Sickle-cell Anemia Therapeutics Market Challenges
Table 14. Sickle-cell Anemia Therapeutics Market Restraints
Table 15. Global Sickle-cell Anemia Therapeutics Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Sickle-cell Anemia Therapeutics Market Share by Players (2018-2023)
Table 17. Global Top Sickle-cell Anemia Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sickle-cell Anemia Therapeutics as of 2022)
Table 18. Ranking of Global Top Sickle-cell Anemia Therapeutics Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Sickle-cell Anemia Therapeutics Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Sickle-cell Anemia Therapeutics Product Solution and Service
Table 22. Date of Enter into Sickle-cell Anemia Therapeutics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Sickle-cell Anemia Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Sickle-cell Anemia Therapeutics Revenue Market Share by Type (2018-2023)
Table 26. Global Sickle-cell Anemia Therapeutics Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Sickle-cell Anemia Therapeutics Revenue Market Share by Type (2024-2033)
Table 28. Global Sickle-cell Anemia Therapeutics Market Size by User (2018-2023) & (US$ Million)
Table 29. Global Sickle-cell Anemia Therapeutics Revenue Market Share by User (2018-2023)
Table 30. Global Sickle-cell Anemia Therapeutics Forecasted Market Size by User (2024-2033) & (US$ Million)
Table 31. Global Sickle-cell Anemia Therapeutics Revenue Market Share by User (2024-2033)
Table 32. North America Sickle-cell Anemia Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 33. North America Sickle-cell Anemia Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Sickle-cell Anemia Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 35. Europe Sickle-cell Anemia Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. Europe Sickle-cell Anemia Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Sickle-cell Anemia Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 38. Asia-Pacific Sickle-cell Anemia Therapeutics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 39. Asia-Pacific Sickle-cell Anemia Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Sickle-cell Anemia Therapeutics Market Size by Region (2024-2033) & (US$ Million)
Table 41. Latin America Sickle-cell Anemia Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 42. Latin America Sickle-cell Anemia Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Sickle-cell Anemia Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 44. Middle East & Africa Sickle-cell Anemia Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Middle East & Africa Sickle-cell Anemia Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Sickle-cell Anemia Therapeutics Market Size by Country (2024-2033) & (US$ Million)
Table 47. Addmedica Company Detail
Table 48. Addmedica Business Overview
Table 49. Addmedica Sickle-cell Anemia Therapeutics Product
Table 50. Addmedica Revenue in Sickle-cell Anemia Therapeutics Business (2018-2023) & (US$ Million)
Table 51. Addmedica Recent Development
Table 52. Gamida Cell Company Detail
Table 53. Gamida Cell Business Overview
Table 54. Gamida Cell Sickle-cell Anemia Therapeutics Product
Table 55. Gamida Cell Revenue in Sickle-cell Anemia Therapeutics Business (2018-2023) & (US$ Million)
Table 56. Gamida Cell Recent Development
Table 57. GlycoMimetics Company Detail
Table 58. GlycoMimetics Business Overview
Table 59. GlycoMimetics Sickle-cell Anemia Therapeutics Product
Table 60. GlycoMimetics Revenue in Sickle-cell Anemia Therapeutics Business (2018-2023) & (US$ Million)
Table 61. GlycoMimetics Recent Development
Table 62. Pfizer Company Detail
Table 63. Pfizer Business Overview
Table 64. Pfizer Sickle-cell Anemia Therapeutics Product
Table 65. Pfizer Revenue in Sickle-cell Anemia Therapeutics Business (2018-2023) & (US$ Million)
Table 66. Pfizer Recent Development
Table 67. Novartis Company Detail
Table 68. Novartis Business Overview
Table 69. Novartis Sickle-cell Anemia Therapeutics Product
Table 70. Novartis Revenue in Sickle-cell Anemia Therapeutics Business (2018-2023) & (US$ Million)
Table 71. Novartis Recent Development
Table 72. Global Blood Therapeutics Company Detail
Table 73. Global Blood Therapeutics Business Overview
Table 74. Global Blood Therapeutics Sickle-cell Anemia Therapeutics Product
Table 75. Global Blood Therapeutics Revenue in Sickle-cell Anemia Therapeutics Business (2018-2023) & (US$ Million)
Table 76. Global Blood Therapeutics Recent Development
Table 77. Micelle BioPharma Company Detail
Table 78. Micelle BioPharma Business Overview
Table 79. Micelle BioPharma Sickle-cell Anemia Therapeutics Product
Table 80. Micelle BioPharma Revenue in Sickle-cell Anemia Therapeutics Business (2018-2023) & (US$ Million)
Table 81. Micelle BioPharma Recent Development
Table 82. Bluebird Bio Company Detail
Table 83. Bluebird Bio Business Overview
Table 84. Bluebird Bio Sickle-cell Anemia Therapeutics Product
Table 85. Bluebird Bio Revenue in Sickle-cell Anemia Therapeutics Business (2018-2023) & (US$ Million)
Table 86. Bluebird Bio Recent Development
Table 87. Prolong Pharmaceuticals Company Detail
Table 88. Prolong Pharmaceuticals Business Overview
Table 89. Prolong Pharmaceuticals Sickle-cell Anemia Therapeutics Product
Table 90. Prolong Pharmaceuticals Revenue in Sickle-cell Anemia Therapeutics Business (2018-2023) & (US$ Million)
Table 91. Prolong Pharmaceuticals Recent Development
Table 92. Modus Therapeutics Company Detail
Table 93. Modus Therapeutics Business Overview
Table 94. Modus Therapeutics Sickle-cell Anemia Therapeutics Product
Table 95. Modus Therapeutics Revenue in Sickle-cell Anemia Therapeutics Business (2018-2023) & (US$ Million)
Table 96. Modus Therapeutics Recent Development
Table 97. Sangamo Biosciences Company Detail
Table 98. Sangamo Biosciences Business Overview
Table 99. Sangamo Biosciences Sickle-cell Anemia Therapeutics Product
Table 100. Sangamo Biosciences Revenue in Sickle-cell Anemia Therapeutics Business (2018-2023) & (US$ Million)
Table 101. Sangamo Biosciences Recent Development
Table 102. Bioverativ Company Detail
Table 103. Bioverativ Business Overview
Table 104. Bioverativ Sickle-cell Anemia Therapeutics Product
Table 105. Bioverativ Revenue in Sickle-cell Anemia Therapeutics Business (2018-2023) & (US$ Million)
Table 106. Bioverativ Recent Development
Table 107. Imara Company Detail
Table 108. Imara Business Overview
Table 109. Imara Sickle-cell Anemia Therapeutics Product
Table 110. Imara Revenue in Sickle-cell Anemia Therapeutics Business (2018-2023) & (US$ Million)
Table 111. Imara Recent Development
Table 112. Ironwood Pharmaceuticals Company Detail
Table 113. Ironwood Pharmaceuticals Business Overview
Table 114. Ironwood Pharmaceuticals Sickle-cell Anemia Therapeutics Product
Table 115. Ironwood Pharmaceuticals Revenue in Sickle-cell Anemia Therapeutics Business (2018-2023) & (US$ Million)
Table 116. Ironwood Pharmaceuticals Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Sickle-cell Anemia Therapeutics Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Sickle-cell Anemia Therapeutics Market Share by Type: 2022 VS 2033
Figure 3. Blood Transfusion Features
Figure 4. Pharmacotherapy Features
Figure 5. Bone Marrow Transplant Features
Figure 6. Global Sickle-cell Anemia Therapeutics Market Size Comparison by User (2023-2033) & (US$ Million)
Figure 7. Global Sickle-cell Anemia Therapeutics Market Share by User: 2022 VS 2033
Figure 8. Child Case Studies
Figure 9. Adult Case Studies
Figure 10. Sickle-cell Anemia Therapeutics Report Years Considered
Figure 11. Global Sickle-cell Anemia Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Sickle-cell Anemia Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Sickle-cell Anemia Therapeutics Market Share by Region: 2022 VS 2033
Figure 14. Global Sickle-cell Anemia Therapeutics Market Share by Players in 2022
Figure 15. Global Top Sickle-cell Anemia Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sickle-cell Anemia Therapeutics as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Sickle-cell Anemia Therapeutics Revenue in 2022
Figure 17. North America Sickle-cell Anemia Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Sickle-cell Anemia Therapeutics Market Share by Country (2018-2033)
Figure 19. United States Sickle-cell Anemia Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Canada Sickle-cell Anemia Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe Sickle-cell Anemia Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Sickle-cell Anemia Therapeutics Market Share by Country (2018-2033)
Figure 23. Germany Sickle-cell Anemia Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. France Sickle-cell Anemia Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. U.K. Sickle-cell Anemia Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Italy Sickle-cell Anemia Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Russia Sickle-cell Anemia Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Nordic Countries Sickle-cell Anemia Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific Sickle-cell Anemia Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Sickle-cell Anemia Therapeutics Market Share by Region (2018-2033)
Figure 31. China Sickle-cell Anemia Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Japan Sickle-cell Anemia Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. South Korea Sickle-cell Anemia Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Southeast Asia Sickle-cell Anemia Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. India Sickle-cell Anemia Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Australia Sickle-cell Anemia Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America Sickle-cell Anemia Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Sickle-cell Anemia Therapeutics Market Share by Country (2018-2033)
Figure 39. Mexico Sickle-cell Anemia Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Brazil Sickle-cell Anemia Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa Sickle-cell Anemia Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Sickle-cell Anemia Therapeutics Market Share by Country (2018-2033)
Figure 43. Turkey Sickle-cell Anemia Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Saudi Arabia Sickle-cell Anemia Therapeutics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Addmedica Revenue Growth Rate in Sickle-cell Anemia Therapeutics Business (2018-2023)
Figure 46. Gamida Cell Revenue Growth Rate in Sickle-cell Anemia Therapeutics Business (2018-2023)
Figure 47. GlycoMimetics Revenue Growth Rate in Sickle-cell Anemia Therapeutics Business (2018-2023)
Figure 48. Pfizer Revenue Growth Rate in Sickle-cell Anemia Therapeutics Business (2018-2023)
Figure 49. Novartis Revenue Growth Rate in Sickle-cell Anemia Therapeutics Business (2018-2023)
Figure 50. Global Blood Therapeutics Revenue Growth Rate in Sickle-cell Anemia Therapeutics Business (2018-2023)
Figure 51. Micelle BioPharma Revenue Growth Rate in Sickle-cell Anemia Therapeutics Business (2018-2023)
Figure 52. Bluebird Bio Revenue Growth Rate in Sickle-cell Anemia Therapeutics Business (2018-2023)
Figure 53. Prolong Pharmaceuticals Revenue Growth Rate in Sickle-cell Anemia Therapeutics Business (2018-2023)
Figure 54. Modus Therapeutics Revenue Growth Rate in Sickle-cell Anemia Therapeutics Business (2018-2023)
Figure 55. Sangamo Biosciences Revenue Growth Rate in Sickle-cell Anemia Therapeutics Business (2018-2023)
Figure 56. Bioverativ Revenue Growth Rate in Sickle-cell Anemia Therapeutics Business (2018-2023)
Figure 57. Imara Revenue Growth Rate in Sickle-cell Anemia Therapeutics Business (2018-2023)
Figure 58. Ironwood Pharmaceuticals Revenue Growth Rate in Sickle-cell Anemia Therapeutics Business (2018-2023)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed